Ranked #3,930 of 8,699 institutional investors
Checkpoint Capital L.P.
San Francisco, CA
$443M
US stock portfolio at live prices · today −$3.4M (−0.76%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $442M
- Change from Q2 2026
- +$52.6M (+13.49%)
- Positions
- 7 · 1 new, 0 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$929K of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesARGX 38.6%RYTM 32.1%RVMD 15.2%IRON 6.87%CYTK 6.01%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ARGX argenx SE | 181,500 | $171M | 38.6% | Added +38% |
| RYTM Rhythm Pharmaceuticals, Inc. | 1,216,574 | $142M | 32.1% | Added +3% |
| RVMD Revolution Medicines, Inc. | 422,911 | $67.4M | 15.2% | Added +3% |
| IRON Disc Medicine, Inc. | 399,830 | $30.4M | 6.87% | Added +67% |
| CYTK Cytokinetics, Incorporated | 517,278 | $26.6M | 6.01% | Added +9% |
| SEPN Septerna, Inc. | 64,000 | $2.5M | 0.57% | New |
| TRVI Trevi Therapeutics, Inc. | 137,000 | $1.9M | 0.42% | Added +83% |